+91%

est. 2Y upside i

HealthcareSeries A

Predicting and preventing heart disease.

Rank

#484

Sector

Digital Therapeutics / HealthTech

Est. Liquidity

~5Y

Data Quality

Data: Medium

Bodyport offers a compelling risk/reward for a job candidate due to its low $9.9M valuation and $3.3M ARR with FDA-cleared technology.

Last updated: July 19, 2026

Bull (25%)+191%

Exit multiple expands to 5x driven by an IPO window or category leadership in digital cardiac monitoring. Projected revenue of $6.7M yields $33.5M exit value, netting ~191% upside after 20% dilution.

Base (50%)+137%

Exit multiple converges to comp midpoint of 4x, giving $26.8M exit value. After 20% dilution, upside of ~137% from $9.9M entry.

Bear (25%)-100%

Multiple compresses to 2x, exit value of $13.4M below $15.8M total funding. Preference stack wipes out common stock, resulting in -100% return.

Est. time to liquidity~5.0 years

Preference Stack Risk

severe

Funding Intensity

160%

Total preferred funding of $15.8M exceeds current valuation of $9.9M, meaning common stock has zero liquidation preference coverage.

Dilution Risk

high

With $3.3M ARR and no recent funding round, a capital raise within 24 months is likely, causing 15-25% dilution.

Secondary Liquidity

none

No secondary market activity; equity is illiquid until an exit event.

Questions to Ask at the Interview

Strategic questions based on Bodyport's data — designed to show you've done your homework.

  • 1

    “How does Bodyport's clinical data (SCALE-HF) translate into sales cycles with hospital systems?”

  • 2

    “What is the plan to achieve positive unit economics and reduce reliance on venture funding?”

  • 3

    “How does the company view its competitive position against incumbents like Medtronic and emerging digital health players?”

Community

Valuation Sentiment

Our model estimates +91% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.